Sagimet Biosciences
Develops oral FASN inhibitor drugs for metabolic and inflammatory diseases.
biotechpharmaceuticals
Open roles
5
−1 in the last 30 days
Reply rate
Not enough data yet.
Time a posting stays open
Not enough data yet.
Postings added vs. removed
Who they hire
What the company's open postings ask for.